About: Trends in pancreatic cancer mortality in Europe, 1955

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Trends in pancreatic cancer mortality in Europe, 1955–1989 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1994 (uk) im Juni 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1994 (ast) scientific article published on 01 June 1994 (en)
publication date	wds:Q57561877-61ECC3C4-8577-4305-816D-B5E8EEE874BF
publication date	1994-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57561877-741EC22E-757A-49D6-8F65-790303411654
language of work or name	English
cites work	wds:Q57561877-2C39472A-9D6A-4081-89DD-A3569B7F5B33 wds:Q57561877-DF08D98A-CE88-4049-BE85-71DE16FE03DE
cites work	Accuracy of diagnosis of pancreatic cancer decreases with increasing age. Long-term survival after pancreatic adenocarcinoma--often a misdiagnosis?
author name string	wds:Q57561877-126E00C4-1601-45AD-8C62-E5914B9021D3 wds:Q57561877-A9ABE516-0063-4758-99FE-4BAA5495D424 wds:Q57561877-B8AB6839-4FA0-43B4-B3CB-76C274496A3A wds:Q57561877-BA203529-4108-4C05-B41E-8577BCCEB390 wds:Q57561877-E74A9390-806D-4DB3-8451-E1F9979BE0A4
author name string	M Porta E Fernandez E Negri F Levi F Lucchini
rdfs:label	Trends in pancreatic cancer mortality in Europe, 1955–1989 (en) Trends in pancreatic cancer mortality in Europe, 1955–1989 (nl)
skos:prefLabel	Trends in pancreatic cancer mortality in Europe, 1955–1989 (en) Trends in pancreatic cancer mortality in Europe, 1955–1989 (nl)
name	Trends in pancreatic cancer mortality in Europe, 1955–1989 (en) Trends in pancreatic cancer mortality in Europe, 1955–1989 (nl)
author	wds:Q57561877-80CD82BE-01B5-4DB0-A4BF-A46BAF43D630
author	Carlo La Vecchia
title	wds:Q57561877-FEBBC2D0-2252-4DA7-8805-970D13F22ABF
title	Trends in pancreatic cancer mortality in Europe, 1955-1989 (en)
page(s)	wds:Q57561877-FAA1BF28-D40D-4428-9C3C-808E5EB70A1D
page(s)	786-792
instance of	wds:Q57561877-DBBF7AB6-BA05-4E46-94F3-7713AF13417F
instance of	scholarly article
main subject	wds:Q57561877-203D606E-52AC-435E-9DF1-FE1992369480 wds:Q57561877-427FDC7D-2B94-42B9-8DF0-36E1527C9C91
main subject	pancreatic cancer cancer research
PubMed ID	wds:Q57561877-7F3E78E4-842C-4A88-A3A6-8382D4DE1A20
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8206673
PubMed ID	8206673
published in	wds:Q57561877-E87EA501-7162-463A-9058-1D04D69964C5
published in	International Journal of Cancer
issue	wds:Q57561877-9FE36C13-9F4A-4E35-84F7-A6C491B3ADCF
volume	wds:Q57561877-54F02F9A-684F-49D5-8093-F4A29802E9EB
issue	6
volume	57
DOI	wds:Q57561877-94B11776-08B4-4F20-A56F-B1B8B8E84BCC
DOI	http://dx.doi.org/10.1002/IJC.2910570605
DOI	10.1002/IJC.2910570605
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57561877
is cites work of	Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine Epidemiology of and risk factors for pancreatic cancer Epidemiology of and risk factors for pancreatic cancer. Cigarette smoke-induced pancreatic damage: experimental data Emerging drugs in pancreatic cancer Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study Epidemiology of pancreatic cancer: an overview. Regional variations in mortality rates of pancreatic cancer in China: Results from 1990-1992 national mortality survey A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group Cancer mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994 Trends in cardiovascular mortality and the quality of vital statistics Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells Pancreatic cancer - a continuing challenge in oncology Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1). Diabetes mellitus in pancreatic cancer patients in the Czech Republic: sex differences Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017. Pancreatic cancer mortality in Serbia from 1991-2010 - a joinpoint analysis. Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer The challenge of pancreatic cancer How useful is it clinically to analyse the K-ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta-analysis Occupations with increased risk of pancreatic cancer in the Swedish population. Comparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancer Occupation and pancreatic cancer in Spain: a case-control study based on job titles. PANKRAS II Study Group Cancer mortality in Switzerland, 1990-1994. The 'two-week' target for the diagnosis of pancreatic carcinoma: an achievable aim? Pancreatic cancer--a major health problem requiring centralization and multi-disciplinary team-work for improved results.
is cites work of	wds:Q33788222-C5E1B249-8800-4C0A-9240-C82C132A8EF9 wds:Q31142695-F8D3AFC2-E9C5-4782-AD87-62D4E108E9B2 wds:Q35779283-25BD0F52-BFA8-4D63-9C95-F6D2BF90D5E6 wds:Q28372029-580C57AE-FCCC-4F19-854E-B8E011B817E2 wds:Q36308886-09EAC6B0-D91B-4762-AAD1-112E901C1B7E wds:Q36017448-815ED7CA-F4DF-48BF-8DC3-389BEC56FC4C wds:Q55036474-50E17577-9598-410C-84FE-40A71A28792C wds:Q73790110-9C7185E9-1BF6-4703-8202-6F74CD622738 wds:Q30438645-A075FEC3-BE1E-41FB-B00F-19A18A807647

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software